Roche, Zealand Pharma Obesity Drug Meets Clinical Trial’s Weight Loss Goals, But Can It Compete?

Petrelintide posted Phase 2 results showing tolerability comparable to a placebo, but average weight loss that was less than what analysts expected. The Zealand Pharma drug, in development under a partnership with Roche, is a peptide engineered to activate the amylin receptor. The post Roche, Zealand Pharma Obesity Drug Meets Clinical Trial’s Weight Loss Goals,…

Read More

California Official Comes out of Retirement To Lead Troubled Mental Health Commission

Veteran California public servant Will Lightbourne has stepped in as interim executive director of the state’s mental health commission after its previous executive director resigned following conflict of interest allegations. Lightbourne served as head of the state’s Department of Social Services for seven years before retiring in 2018 and had already returned to service once,…

Read More

June 11 Virtual Event: How the Trump Administration and Congress Are Reshaping the Affordable Care Act’s Marketplaces: Views from the States

Through regulations and the House budget reconciliation bill, significant changes are being considered by Congress and the Trump Administration for how the Affordable Care Act’s health insurance Marketplaces would work. At the same time, the enhanced tax credits that have made Marketplace coverage more affordable and driven record enrollment are set to expire at the…More

Read More

How to Fix the Paradox of Primary Care

By MATTHEW HOLT If health policy wonks believe anything it’s that primary care is a good thing. In theory we should all have strong relationships with our primary care doctors. They should navigate us around the health system and be arriving on our doorsteps like Marcus Welby MD when needed. Wonks like me believe that…

Read More